Boerhaave's syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report. [PDF]
Aubrey JM, Benner C, Lam GT.
europepmc +1 more source
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Respiratory Disorders. [PDF]
Russjan E, Zając D, Kaczyńska K.
europepmc +1 more source
Discontinuation of glucagon-like peptide-1 receptor agonists among US adults: A national survey. [PDF]
DiStefano MJ +5 more
europepmc +1 more source
Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review. [PDF]
Alsanosi ZY +10 more
europepmc +1 more source
Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists. [PDF]
Kopp KL +9 more
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms. [PDF]
Eiden C +7 more
europepmc +1 more source
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review. [PDF]
Chan TH +5 more
europepmc +1 more source
Novel Compounds as Glucagon-Like Peptide‑1 Receptor Agonists for Treating Diabetes. [PDF]
Sabnis RW.
europepmc +1 more source
Use of Glucagon-Like Peptide-1 Receptor Agonists in Danish Adolescents and Young Adults 2018-2025. [PDF]
Kildegaard H +4 more
europepmc +1 more source

